Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice-Reference-Cited by-同舟云学术

Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice

Published:2012-05 Issue:5 Volume:142 Page:1218-1228.e1
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Liu Jie,Zhou Liang,Xiong Keming,Godlewski Grzegorz,Mukhopadhyay Bani,Tam Joseph,Yin Shi,Gao Peter,Shan Xin,Pickel James,Bataller Ramon,O'hare James,Scherer Thomas,Buettner Christoph,Kunos George

Funder

National Institute on Alcohol Abuse and Alcoholism

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference56 articles.

1. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis;Biddinger;Cell Metab,2008

2. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism;Matsumoto;J Clin Invest,2006

3. Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo;Ramnanan;Diabetes,2010

4. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans;Petersen;J Clin Invest,1998

5. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor;Brown;Cell,1997

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy in diet‐induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837;British Journal of Pharmacology;2024-06-17

2. Canine Atopic Dermatitis: Systemic Indicators of Cannabis Therapy;ACTA SCI VET;2024

3. Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis;Exploration of Digestive Diseases;2023-10-25

4. Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB1 Receptor Antagonists after the Fall;Drugs and Drug Candidates;2023-08-30

5. The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma;Environmental Research;2023-07